Axol Bioscience Ltd. Revenue and Competitors

Cambridge,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Axol Bioscience Ltd.'s estimated annual revenue is currently $8.1M per year.(i)
  • Axol Bioscience Ltd.'s estimated revenue per employee is $155,000

Employee Data

  • Axol Bioscience Ltd. has 52 Employees.(i)
  • Axol Bioscience Ltd. grew their employee count by 21% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$15.3M99-49%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.5M29-6%N/AN/A
#10
$9.6M62-7%N/AN/A
Add Company

Axol Bioscience are human cell culture specialists, providing primary cells and iPSC derived cells with a wide range of functionally and physiologically, disease relevant backgrounds, together with optimised media and growth supplements. all of which are suitable for assays in basic life science research, drug discovery and toxicology assessment. Our cells are provided cryopreserved, in a vial, as assay-ready live plated cells or as part of a custom service, where we use our extensive expertise to reprogram to iPS cells and differentiate into multiple cell types according to your specifications. Our mission is to create the best human cell biology research tools, to advance medical research and drug discovery. Axol is headquartered and maintains production on the Chesterford Research Park, a location renowned for inspiring innovation and success, located in Cambridge, UK.

keywords:N/A

N/A

Total Funding

52

Number of Employees

$8.1M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Axol Bioscience Ltd. News

2022-04-17 - Global Induced Pluripotent Stem Cells Production Market ...

Axol Bioscience Ltd. Evotec; Hitachi Ltd. Merck KGaA; REPROCELL Inc. Fate Therapeutics; Thermo Fisher Scientific, Inc. StemCellFactory III; Applied StemCell Inc...

2022-04-06 - Axol Bioscience Raises £3.2 million GBP (c. $4.2 million USD)

CAMBRIDGE, England--(BUSINESS WIRE)--Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization...

2022-04-06 - Axol Bioscience Raises £3.2M In Funding

Axol Bioscience Ltd., a Cambridge, England, UK-based provider of iPSC-derived cells, media, and characterization services for life science...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.6M52N/AN/A
#2
$6.8M52-7%N/A
#3
$6.8M520%N/A
#4
$4M52-22%$40.3M
#5
$14.3M5213%N/A